Efficacy of 6 courses CHOP plus Rituximab followed by myeloablative radiochemotherapy and autologous stem cell transplantation vs. alternating courses of 3x CHOP and 3x DHAP plus Rituximab followed by high dose ARA-C containing myeloablative regimen and autologous stem cell transplantation (#194)
Laufzeit: 01.01.2012 - 31.12.2019